Canada - English - Health Canada

aspen pharmacare canada inc. - lidocaine hydrochloride; epinephrine (epinephrine bitartrate) - solution - 20mg; 0.005mg - lidocaine hydrochloride 20mg; epinephrine (epinephrine bitartrate) 0.005mg - local anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine, quantity: 100 mg/ml - spray, solution - excipient ingredients: ethanol; menthol; purified water; macrogol 400; saccharin; flavour - xylocaine 10% pump spray is used for surface anaesthesia of the mucous membranes prior to the following procedures:,otorhinolaryngology:,to prepare for puncture of the maxillary sinus; for analgesia of the pharynx to prevent gagging and stress reactions when inserting instruments.,dental practice:,before injections, treating minor abscesses, suture removal, deep scaling and to prevent gagging when taking intraoral impressions and x-rays.,general anaesthesia:,to prevent coughing with an endotracheal tube in situ during light surgical anaesthesia.,obstetrics:,during the final stages of delivery and before episiotomy and perineal suturing as supplementary pain control.

United States - English - NLM (National Library of Medicine)

cardinal health - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - xylocaine (lidocaine hcl) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Ireland - English - HPRA (Health Products Regulatory Authority)

dentsply detrey gmbh - lidocaine hydrochloride; adrenaline (epinephrine) tartrate - solution for injection - 2 percent weight/volume - amides; prilocaine

United States - English - NLM (National Library of Medicine)

dentsply pharmaceutical - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 20 mg in 1 ml - 2% xylocaine dental solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques. only accepted procedures for these techniques as described in standard textbooks are recommended. 2% xylocaine dental is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any components of the injectable formulations.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline;  ; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous; adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline   lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment nitrogen as nitrogen for injection sodium chloride sodium hydroxide as 2m solution for ph adjustment sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 0.0227 mg/ml equivalent to 12.5 µg/ml adrenaline; lidocaine hydrochloride 20 mg/ml;  ;   - solution for injection - active: adrenaline acid tartrate 0.0227 mg/ml equivalent to 12.5 µg/ml adrenaline lidocaine hydrochloride 20 mg/ml     excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - chlorhexidine gluconate 0.5mg; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous;  ;   - topical gel - 20mg/0.5mg - active: chlorhexidine gluconate 0.5mg lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous     excipient: methylcellulose purified water sodium hydroxide

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - chlorhexidine gluconate 0.5mg (as 20% solution); lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous;  ;   - topical gel - 20mg/0.5mg - active: chlorhexidine gluconate 0.5mg (as 20% solution) lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous     excipient: hydrochloric acid hypromellose as hydroxypropyl methylcellulose 4000cps approx sodium hydroxide water for injection

Egypt - English - EDA (Egyptian Drug Authority)

astra zeneca-egypt - topical gel - 2 %